Navigation Links
BioSpecifics Technologies Corp. to Present at Two Upcoming Investor Conferences in September

LYNBROOK, N.Y., Sept. 4, 2012 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in Europe and Eurasia, today announced that Tom Wegman, President of BioSpecifics, will present at the following two upcoming investor conferences in September:

  • Rodman & Renshaw 14th Annual Healthcare Conference
    Monday, September 10, 2012 at 11:40 am EDT
    New York, NY
  • ThinkEquity 9th Annual Growth Conference
    Thursday, September 13, 2012 at 9:30 am EDT
    New York, NY

The live webcasts of these presentations may be accessed under "Calendar of Events" in the Investor Relations section of the BioSpecifics' website at A replay of the webcasts will also be available on the Company's website following the presentations.

About BioSpecifics Technologies Corp.

BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed injectable collagenase (XIAFLEX®) for twelve clinical indications. Currently, XIAFLEX is marketed in the U.S. for the treatment of adult Dupuytren's contracture patients with a palpable cord by Auxilium Pharmaceuticals, Inc. (Auxilium) and is also in clinical development for the treatment of several additional promising indications. Auxilium has reported positive top-line results from two recently completed Phase III clinical trials for Peyronie's disease and is also testing XIAFLEX for frozen shoulder syndrome (adhesive capsulitis) and cellulite in Phase IIa and Phase Ib clinical trials, respectively. BioSpecifics is currently managing the clinical development of XIAFLEX for the treatment of human lipoma and canine lipoma, which are both in Phase II clinical trials.  Auxilium has entered into three strategic partnerships for development and commercialization outside the U.S. of injectable collagenase for Dupuytren's contracture and Peyronie's disease. Pfizer Inc. has rights in Europe and Eurasia and injectable collagenase is currently marketed as XIAPEX® for Dupuytren's contracture in select European countries. Asahi Kasei Pharma Corporation has rights in Japan and Actelion Pharmaceuticals Canada Inc. has rights in Canada, Australia, Brazil and Mexico. For more information, please visit

SOURCE BioSpecifics Technologies Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BioSpecifics Technologies Corp. To Present at Stifel Nicolaus Weisel Healthcare Conference 2012
2. BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2012 Financial Results on August 9, 2012
3. BioSpecifics Technologies Corp. Announces Rescheduled First Quarter 2012 Financial Results Conference Call to May 10, 2012
4. Medisafe 1 Technologies in Advanced Negotiations for $7MM Perpetual License Sale
5. Global E-Clinical Trial Technologies Industry
6. Antifungal Drugs: Technologies and Global Markets
7. Cleveland Clinics 2012 Medical Innovation Summit Highlights Orthopaedic Technologies
8. Breast Cancer Diagnostic and Drug Technologies: Global Markets
9. ARAMARK Healthcare Technologies Taps Robert Steele to Lead ReMedPar
10. Montmed to Participate in 2013 Advanced Technologies and Treatments for Diabetes Conference
11. U.S. Navy Awards Multi-Million Dollar Contract to Innovation for Pharmacy Automation Technologies
Post Your Comments:
(Date:11/30/2015)... , Nov. 30, 2015  DURECT ... that Matt Hogan , Chief Financial ... Healthcare Conference on Tuesday, December 8 at ... being held at the Westin Grand Central ... be available for one-on-one meetings at this ...
(Date:11/30/2015)... SAN FRANCISCO , Nov. 30, 2015 ... and Designers of Things (DoT ) co-located events ... Printing and the Internet of Things, will draw more ... San Jose Convention Center. The events, combined ... their latest technologies. --> ...
(Date:11/30/2015)... CHICAGO , Nov. 30, 2015 Nautilus ... next-generation Radiology Image Management platform ( ). The ... was announced from RSNA 2015 (Radiology Society North America) ... Radiology conference in the U.S. --> ... radiology platform that enables access to radiology studies worldwide ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... ... states in the U.S. require dental technicians to be certified or obtain continuing ... NADL created the “What’s In Your Mouth?” campaign to inform dentists that the ...
(Date:11/30/2015)... Los Angeles, CA (PRWEB) , ... November 30, 2015 , ... ... such as grafts, strip harvesting and follicular unit extraction. These techniques and procedures have ... of helping patients suffering from hair loss. While Dr. Parsa Mohebi, M.D. has utilized ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... its annual fundraising campaign to raise funds for its research, education, support, and ... of the organization’s annual funding. , The Mesothelioma Applied Research Foundation, which also ...
(Date:11/30/2015)... ... , ... Cycling, running, and walking are regular Sunday activities for many South ... 28, 2016. , That’s when the 7th annual ANF Group Tour de Broward ... and families at Joe DiMaggio Children’s Hospital. , The community fundraiser, sponsored ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... athletic teams looking to maximize recovery through quality sleep. Tim DiFrancesco, training coach ... get a better night’s sleep. ChiliPad precisely regulates the surface temperature of each ...
Breaking Medicine News(10 mins):